亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study

医学 急性肾损伤 肌酐 肾功能 优势比 内科学 肾脏疾病 临床终点 安慰剂 肾脏替代疗法 外科 入射(几何) 随机对照试验 泌尿科 病理 物理 替代医学 光学
作者
Matthias Thielmann,David Corteville,Gábor Szabó,Madhav Swaminathan,André Lamy,Lukas Lehner,Craig Brown,Nicolas Noiseux,Mohamed G. Atta,Elizabeth C. Squiers,Shai Erlich,Daniel Rothenstein,Bruce A. Molitoris,C. David Mazer
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:144 (14): 1133-1144 被引量:62
标识
DOI:10.1161/circulationaha.120.053029
摘要

Acute kidney injury (AKI) affects up to 30% of patients undergoing cardiac surgery, leading to increased in-hospital and long-term morbidity and mortality. Teprasiran is a novel small interfering RNA that temporarily inhibits p53-mediated cell death that underlies AKI.This prospective, multicenter, double-blind, randomized, controlled phase 2 trial evaluated the efficacy and safety of a single 10 mg/kg dose of teprasiran versus placebo (1:1), in reducing the incidence, severity, and duration of AKI after cardiac surgery in high-risk patients. The primary end point was the proportion of patients who developed AKI determined by serum creatinine by postoperative day 5. Other end points included AKI severity and duration using various prespecified criteria. To inform future clinical development, a composite end point of major adverse kidney events at day 90, including death, renal replacement therapy, and ≥25% reduction of estimated glomerular filtration rate was assessed. Both serum creatinine and serum cystatin-C were used for estimated glomerular filtration rate assessments.A total of 360 patients were randomly assigned in 41 centers; 341 dosed patients were 73±7.5 years of age (mean±SD), 72% were men, and median European System for Cardiac Operative Risk Evaluation score was 2.6%. Demographics and surgical parameters were similar between groups. AKI incidence was 37% for teprasiran- versus 50% for placebo-treated patients, a 12.8% absolute risk reduction, P=0.02; odds ratio, 0.58 (95% CI, 0.37-0.92). AKI severity and duration were also improved with teprasiran: 2.5% of teprasiran- versus 6.7% of placebo-treated patients had grade 3 AKI; 7% teprasiran- versus 13% placebo-treated patients had AKI lasting for 5 days. No significant difference was observed for the major adverse kidney events at day 90 composite in the overall population. No safety issues were identified with teprasiran treatment.The incidence, severity, and duration of early AKI in high-risk patients undergoing cardiac surgery were significantly reduced after teprasiran administration. A phase 3 study with a major adverse kidney event at day 90 primary outcome that has recently completed enrollment was designed on the basis of these findings (NCT03510897). Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02610283.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1分钟前
Liufgui应助Dave采纳,获得10
1分钟前
Benhnhk21发布了新的文献求助10
1分钟前
yydragen应助yyds采纳,获得10
1分钟前
Hisam完成签到,获得积分10
1分钟前
lhy完成签到,获得积分10
1分钟前
lhy发布了新的文献求助10
1分钟前
1分钟前
积极的台灯应助Benhnhk21采纳,获得10
1分钟前
Hisam发布了新的文献求助10
1分钟前
yyds完成签到,获得积分0
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
木木完成签到 ,获得积分10
2分钟前
2分钟前
董可以发布了新的文献求助10
2分钟前
小马甲应助董可以采纳,获得10
2分钟前
3分钟前
Boren发布了新的文献求助10
3分钟前
梨子完成签到,获得积分10
3分钟前
Boren完成签到,获得积分10
3分钟前
WerWu完成签到,获得积分10
4分钟前
彭于晏应助Dc采纳,获得10
5分钟前
6分钟前
情怀应助科研通管家采纳,获得10
6分钟前
7分钟前
Dc发布了新的文献求助10
7分钟前
Dc完成签到,获得积分10
7分钟前
7分钟前
幽默平安发布了新的文献求助10
7分钟前
科研通AI2S应助科研通管家采纳,获得10
8分钟前
9分钟前
9分钟前
9分钟前
小禾一定行完成签到 ,获得积分10
9分钟前
inkoin发布了新的文献求助10
9分钟前
科研通AI2S应助科研通管家采纳,获得10
10分钟前
inkoin完成签到,获得积分10
10分钟前
11分钟前
积极的台灯应助Akitten采纳,获得10
11分钟前
隐形曼青应助务实书包采纳,获得10
11分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990290
求助须知:如何正确求助?哪些是违规求助? 3532146
关于积分的说明 11256472
捐赠科研通 3271042
什么是DOI,文献DOI怎么找? 1805197
邀请新用户注册赠送积分活动 882302
科研通“疑难数据库(出版商)”最低求助积分说明 809234